Matthew McDonald

Matthew McDonald currently serves as the Sr. Area Business Director for Rigel Pharmaceuticals Inc., overseeing a team focused on hematologic diseases in the US East region and Puerto Rico. Additionally, McDonald is an Executive Board Member for the American Lung Association. Previously, a significant tenure at AstraZeneca included roles as Commercial Business Director for Respiratory and Immunology and Oncology District Sales Manager. Earlier experience at Celgene involved managing global marketing for Abraxane in lung cancer, while positions at Amgen and Janssen Inc. provided extensive expertise in oncology sales and training. Matthew McDonald holds a Bachelor of Arts Degree in Pre-Law and Political Science from the University of Massachusetts Amherst.